15 results
10-K
2023 FY
AUTL
Autolus Therapeutics plc
21 Mar 24
Annual report
4:55pm
the culture, and residual cells did not possess any intrinsic anti-GD2 activity. This safety switch activation was also observed in vivo in a mouse model
6-K
EX-1
AUTL
Autolus Therapeutics plc
1 Jul 22
Current report (foreign)
5:15pm
in the section of the Directors’ Report entitled “Employee engagement culture and values”. These core principles—Focus, Respect, Integrity … growth strategy and aligns with the Group’s values of integrity and respect. The Group recognises that by valuing and promoting a culture of diversity
6-K
EX-1
AUTL
Autolus Therapeutics plc
30 Jun 21
Annual Report and Accounts
6:05am
engagement culture and values”. These core principles-Focus, Respect, Integrity and Breakthrough—inform and support our directors as they provide guidance … with the Group’s values of integrity and respect. The Company recognises that by valuing and promoting a culture of diversity and inclusion, it enables employees
6-K
EX-1
wfrp3qhipdr54wvxan
26 May 20
Current report (foreign)
4:31pm
6-K
EX-1
y8yhpxnscqi55 j2v
15 Mar 19
Annual Report and Accounts
5:26pm
20-F
g989p5u8z4ms9v6he71
23 Nov 18
Annual report (foreign)
12:00am
424B4
nm56ivhj by
22 Jun 18
Prospectus supplement with pricing info
4:02pm
F-1/A
6s1zwpb gwoi
19 Jun 18
Registration statement (foreign) (amended)
8:05am
F-1/A
sqj2omw3u2n4
8 Jun 18
Registration statement (foreign) (amended)
6:25am
F-1/A
gp62tppwxdppi
10 May 18
Registration statement (foreign) (amended)
5:19pm
F-1
3lqi0vhvt 0qa
7 May 18
Registration statement (foreign)
4:45pm
- Prev
- 1
- Next